MYX mayne pharma group limited

Ann: MAYNE PHARMA provides FDA update on generic NUVARING, page-18

  1. 7,280 Posts.
    lightbulb Created with Sketch. 447
    Approval or no approval. Market does not care for NUVARING any more. Market has also written off this mob and has no hope from them ALREADY
    AS market has not even sneezed over this disclosure.

    Also means all this WAS ALREADY PRICED IN BY THE MARKET
    as market knows it ALL IN ADVANCE....... WINK WINK WINK
    Last edited by Chartsshout: 07/10/21
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.07
Change
0.050(1.00%)
Mkt cap ! $411.9M
Open High Low Value Volume
$5.00 $5.14 $4.94 $712.4K 141.2K

Buyers (Bids)

No. Vol. Price($)
1 1059 $5.07
 

Sellers (Offers)

Price($) Vol. No.
$5.13 1000 1
View Market Depth
Last trade - 16.10pm 26/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.